Literature DB >> 23139140

Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study.

Balwinder Singh1, Andrew C Hanson2, Rabe Alhurani1, Shihan Wang3, Vitaly Herasevich4, Rodrigo Cartin-Ceba1, Daryl J Kor4, Naseema Gangat5, Guangxi Li6.   

Abstract

BACKGROUND: The incidence and outcomes of disseminated intravascular coagulation (DIC) are incompletely defined. Therefore, we aimed to evaluate the trends in incidence and outcomes of critically ill patients with DIC.
METHODS: We conducted a population-based, retrospective cohort study evaluating consecutively admitted adult (≥ 18 years old) critically ill patients with DIC at the Mayo Clinic, Minnesota, from 2004 to 2010. DIC was diagnosed according to the International Society on Thrombosis and Hemostasis' overt DIC algorithm. Patients given a diagnosis of heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, Child Pugh class C, or any known congenital or acquired coagulation disorders were excluded.
RESULTS: Of the 8,089 Olmsted County resident ICU admissions, a total of 154 patients met the DIC inclusion criteria. The overall incidence rate of DIC/100,000 person-years decreased from 26.2 (95% CI, 17.1-38.4) in 2004 to 18.6 (95% CI, 11.3-28.7) in 2010. The incidence rate of DIC increased with age in both men and women and was consistently higher in men, with the exception of the age group 18 to 39 years. The incidence rate/100,000 person-years of DIC in men decreased from 41.6 (95% CI, 25.4-64.2) in 2004 to 21.2 (95% CI, 10.6 37.9) in 2010 (P = .01), whereas in women, it did not change significantly (P = .79). The case fatality rate did not change significantly during the study period.
CONCLUSIONS: The incidence of DIC has decreased over the past decade, significantly in men, although the mortality rate remains the same. This is in agreement with trends in other critical care syndromes and could be attributable to improvements in health care delivery.

Entities:  

Mesh:

Year:  2013        PMID: 23139140     DOI: 10.1378/chest.12-2112

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  The recent time trend of outcomes of disseminated intravascular coagulation in Japan: an observational study based on a national administrative database.

Authors:  Atsuhiko Murata; Kohji Okamoto; Toshihiko Mayumi; Keiji Muramatsu; Shinya Matsuda
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

Review 3.  Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2020-09-09       Impact factor: 2.490

Review 4.  DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Authors:  Offer Erez; Maha Othman; Anat Rabinovich; Elad Leron; Francesca Gotsch; Jecko Thachil
Journal:  J Blood Med       Date:  2022-01-06

5.  Overt Disseminated Intravascular Coagulation with Severe Hypofibrinogenemia During Veno-Venous Extracorporeal Membrane Oxygenation.

Authors:  Stephen Yang; Brittney Williams; David Kaczorowski; Michael Mazzeffi
Journal:  J Extra Corpor Technol       Date:  2022-06

6.  Exploring the epidemiology of disseminated intravascular coagulation: protocol for the DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study.

Authors:  Simon Flæng; Søren Nygaard; Asger Granfeldt; Anne-Mette Hvas; Henrik Toft Sørensen; Jecko Thachil; Kasper Adelborg
Journal:  BMJ Open       Date:  2022-07-14       Impact factor: 3.006

7.  Time Trends of the Outcomes and Treatment Options for Disseminated Intravascular Coagulation: A Nationwide Observational Study in Japan.

Authors:  Kazuma Yamakawa; Hiroyuki Ohbe; Kohei Taniguchi; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  JMA J       Date:  2020-09-23

8.  [Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients].

Authors:  G Moreno; R Carbonell; M Bodí; A Rodríguez
Journal:  Med Intensiva (Engl Ed)       Date:  2020-06-17

9.  Recombinant thrombomodulin for secondary thrombotic thrombocytopenic purpura.

Authors:  Kensuke Nakamura; Ryota Inokuchi; Takahiro Hiruma; Kazuma Ohshima; Tomohiro Sonoo; Kurato Tokunaga; Kent Doi; Susumu Nakajima
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 10.  Snakebite Associated Thrombotic Microangiopathy and Recommendations for Clinical Practice.

Authors:  Tina Noutsos; Bart J Currie; Eranga S Wijewickrama; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2022-01-14       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.